Torley Helen bought HALO
October 2, 2025 · Form 4 insider transaction
Torley Helen bought 20,000 shares of Halozyme Therapeutics, Inc. at $8.11 per share, a transaction worth $162.2K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
20,000
Price
$8.11
Total value
$162.2K
InsiderTorley Helen
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateOctober 2, 2025
Filing dateOctober 3, 2025
Shares owned after753,719
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 21, 2025 in accordance with Rule 10b5-1. The sales of common shares reported on this Form 4 represent shares that were acquired following exercise of stock options with a ten-year term expiring in less than one year in February 2026.